Health Catalyst, INC 10-Q quarterly reports

Health Catalyst, Inc. reported a 13% decrease in total revenue for Q2 2026 compared to the prior year, driven by client churn and down-selling related to platform migrations, alongside a significant goodwill impairment charge.

Health Catalyst Inc. reported a significant increase in net loss for Q1 2026, primarily due to a $95.5 million goodwill impairment, while total revenue decreased year-over-year.

Health Catalyst reports a widened net loss in Q3 2025, driven by a significant goodwill impairment charge and restructuring costs, despite technology revenue growth.

Health Catalyst, Inc. reported a significantly wider net loss in Q2 2025, primarily driven by a substantial goodwill impairment charge, despite modest revenue growth.

Health Catalyst's Q1 2025 revenue increased by 6% year-over-year, driven by technology subscriptions, while the company continues to navigate a challenging macroeconomic environment and strategic restructuring.

Health Catalyst's Q3 2024 results show a 3% increase in revenue compared to the same period last year, alongside a reduced net loss.

Health Catalyst's second quarter 2024 results show stable revenue and a reduction in net losses compared to the same period last year.

Health Catalyst's first quarter 2024 results show stable revenue with a net loss, as the company navigates a challenging macroeconomic environment and strategic transitions.